Table 1

Results of mixed effects model using colonoscopy completion as the outcome measure

Trainee and training factorsNo of trainees (%)OR (95% CIs)p Value
No of procedures
 <5065 (22)Reference
 50–9977 (26)1.80 (1.50 to 2.20)<0.01
 100–14955 (19)4.20 (3.80 to 4.70)<0.01
 150–19946 (15)4.50 (4.0 to 5.00)<0.01
 200–24928 (9.5)4.60 (4.00 to 5.10)<0.01
 250–29916 (5.5)7.70 (6.90 to 8.40)<0.01
 300–3499 (3)6.40 (5.50 to 7.20)<0.01
Adjusted intensity2971.10 (1.00 to 1.10)0.034
No of trainers2970.99 (0.97 to 1.00)0.68
Trainee specialty
 Gastroenterologist167 (56)Reference
 Gastrointestinal surgeon97 (33)1.60 (1.30 to 2.00)0.01
 Nurse endoscopist32 (11)1.30 (0.70 to 1.90)0.40
 General practitioner1 (0.34)1.20 (−1.10 to 3.40)0.89
Breaks in training >6 months
 No228 (77)Reference
 Yes69 (23)1.10 (0.78 to 1.40)0.56
Flexible sigmoidoscopy experience >100
 No249 (84)Reference
 Yes24 (8.1)2.40 (1.80 to 3.00)<0.01
 Unknown24 (8.1)1.00 (0.48 to 1.50)0.98
OGD experience >100
 No187 (63)Reference
 Yes69 (23)1.20 (0.84 to 1.60)0.30
 Unknown41 (14)1.40 (0.94 to 1.90)0.98
Completed colonoscopy course
 No100 (34)Reference
 Yes197 (66)0.88 (0.58 to 1.20)0.38
Baseline level of experience
 None166 (56)Reference
 1–2061 (21)1.30 (0.85 to 1.70)0.27
 21–5070 (24)1.60 (1.20 to 2.10)0.038
Source of baseline data
 JAG e-portfolio92 (31)Reference
 Survey205 (69)0.85 (0.42 to 1.30)0.45
Patient factorsNo of colonoscopies (%)OR (95% CIs)p Value
Age (years)
 <404 563 (12)Reference
 40–6417 934 (49)1.10 (1.00 to 1.20)0.063
 >6514 233 (39)0.85 (0.77 to 0.94)<0.01
Gender
 Male19 450 (53)Reference
 Female17 280 (47)0.64 (0.59 to 0.69)<0.01
Diagnosis at colonoscopy (reference: not present)
 +Diagnosis available30 458 (83)1.80 (1.70 to 1.90)<0.01
 +Colorectal cancer688 (2.3)0.50 (0.33 to 0.68)<0.01
 +Polyps8 126 (27)1.10 (1.00 to 1.10)0.072
 +IBD3 088 (10)0.98 (0.89 to 1.10)0.75
 +Diverticular disease5 455 (18)0.86 (0.79 to 0.94)<0.01
 +Stricture495 (1.6)0.16 (-0.06 to 0.38)<0.01
Random effectsSD
 Trainee1.00
 Hospital0.88
  • Percentages, ORs and p values given to 2 significant figures.

  • JAG, Joint Advisory Group; OGD, oesophagogastric duodenoscopy.